Home
>
National Drug Code (NDC)
>
Digoxin
Digoxin - 50564-545-10 - (Digoxin)
Drug Information of Digoxin
| Product NDC: | 50564-545 |
| Proprietary Name: | Digoxin |
| Non Proprietary Name: | Digoxin |
| Active Ingredient(s): | 250 ug/1 & nbsp; Digoxin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Digoxin
| Product NDC: | 50564-545 |
| Labeler Name: | Jerome Stevens Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076268 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020726 |
Package Information of Digoxin
| Package NDC: | 50564-545-10 |
| Package Description: | 1000 TABLET in 1 BOTTLE (50564-545-10) |
NDC Information of Digoxin
| NDC Code | 50564-545-10 |
| Proprietary Name | Digoxin |
| Package Description | 1000 TABLET in 1 BOTTLE (50564-545-10) |
| Product NDC | 50564-545 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Digoxin |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020726 |
| Marketing Category Name | ANDA |
| Labeler Name | Jerome Stevens Pharmaceuticals, Inc. |
| Substance Name | DIGOXIN |
| Strength Number | 250 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |
